• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCL5-CCR5介导的T细胞凋亡:对糖胺聚糖结合和CCL5聚集的需求。

CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation.

作者信息

Murooka Thomas T, Wong Mark M, Rahbar Ramtin, Majchrzak-Kita Beata, Proudfoot Amanda E I, Fish Eleanor N

机构信息

Division of Cellular and Molecular Biology, Toronto General Research Institute, University Health Network, Department of Immunology, University of Toronto, Toronto, Ontario, M5G 2M1, Canada.

出版信息

J Biol Chem. 2006 Sep 1;281(35):25184-94. doi: 10.1074/jbc.M603912200. Epub 2006 Jun 28.

DOI:10.1074/jbc.M603912200
PMID:16807236
Abstract

CCL5 (RANTES (regulated on activation normal T cell expressed and secreted)) and its cognate receptor, CCR5, have been implicated in T cell activation. CCL5 binding to glycosaminoglycans (GAGs) on the cell surface or in extracellular matrix sequesters CCL5, thereby immobilizing CCL5 to provide the directional signal. In two CCR5-expressing human T cell lines, PM1.CCR5 and MOLT4.CCR5, and in human peripheral blood-derived T cells, micromolar concentrations of CCL5 induce apoptosis. CCL5-induced cell death involves the cytosolic release of cytochrome c, the activation of caspase-9 and caspase-3, and poly(ADP-ribose) polymerase cleavage. CCL5-induced apoptosis is CCR5-dependent, since native PM1 and MOLT4 cells lacking CCR5 expression are resistant to CCL5-induced cell death. Furthermore, we implicate tyrosine 339 as a critical residue involved in CCL5-induced apoptosis, since PM1 cells expressing a tyrosine mutant receptor, CCR5Y339F, do not undergo apoptosis. We show that CCL5-CCR5-mediated apoptosis is dependent on cell surface GAG binding. The addition of exogenous heparin and chondroitin sulfate and GAG digestion from the cell surface protect cells from apoptosis. Moreover, the non-GAG binding variant, (44AANA47)-CCL5, fails to induce apoptosis. To address the role of aggregation in CCL5-mediated apoptosis, nonaggregating CCL5 mutant E66S, which forms dimers, and E26A, which form tetramers at micromolar concentrations, were utilized. Unlike native CCL5, the E66S mutant fails to induce apoptosis, suggesting that tetramers are the minimal higher ordered CCL5 aggregates required for CCL5-induced apoptosis. Viewed altogether, these data suggest that CCL5-GAG binding and CCL5 aggregation are important for CCL5 activity in T cells, specifically in the context of CCR5-mediated apoptosis.

摘要

CCL5(调节激活正常T细胞表达和分泌因子(RANTES))及其同源受体CCR5与T细胞激活有关。CCL5与细胞表面或细胞外基质中的糖胺聚糖(GAGs)结合会隔离CCL5,从而固定CCL5以提供定向信号。在两种表达CCR5的人T细胞系PM1.CCR5和MOLT4.CCR5以及人外周血来源的T细胞中,微摩尔浓度的CCL5可诱导细胞凋亡。CCL5诱导的细胞死亡涉及细胞色素c的胞质释放、caspase-9和caspase-3的激活以及聚(ADP-核糖)聚合酶的裂解。CCL5诱导的细胞凋亡是CCR5依赖性的,因为缺乏CCR5表达的天然PM1和MOLT4细胞对CCL5诱导的细胞死亡具有抗性。此外,我们认为酪氨酸339是参与CCL5诱导细胞凋亡的关键残基,因为表达酪氨酸突变受体CCR5Y339F的PM1细胞不会发生凋亡。我们表明,CCL5-CCR5介导的细胞凋亡依赖于细胞表面GAG结合。添加外源性肝素和硫酸软骨素以及从细胞表面消化GAG可保护细胞免于凋亡。此外,非GAG结合变体(44AANA47)-CCL5不能诱导细胞凋亡。为了研究聚集在CCL5介导的细胞凋亡中的作用,使用了微摩尔浓度下形成二聚体的非聚集CCL5突变体E66S和形成四聚体的E26A。与天然CCL5不同,E66S突变体不能诱导细胞凋亡,这表明四聚体是CCL5诱导细胞凋亡所需的最小高阶CCL5聚集体。总体而言,这些数据表明CCL5-GAG结合和CCL5聚集对于T细胞中CCL5的活性很重要,特别是在CCR5介导的细胞凋亡的背景下。

相似文献

1
CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation.CCL5-CCR5介导的T细胞凋亡:对糖胺聚糖结合和CCL5聚集的需求。
J Biol Chem. 2006 Sep 1;281(35):25184-94. doi: 10.1074/jbc.M603912200. Epub 2006 Jun 28.
2
Expression of CCL5 (RANTES) and CCR5 in prostate cancer.CCL5(调节激活正常T细胞表达和分泌因子)和CCR5在前列腺癌中的表达
Prostate. 2006 Feb 1;66(2):124-34. doi: 10.1002/pros.20306.
3
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.RANTES/CCL5 诱导的促血管生成作用依赖于 CCR1、CCR5 和糖胺聚糖。
Angiogenesis. 2012 Dec;15(4):727-44. doi: 10.1007/s10456-012-9285-x. Epub 2012 Jun 30.
4
Structural and functional analysis of the RANTES-glycosaminoglycans interactions.RANTES与糖胺聚糖相互作用的结构与功能分析
Biochemistry. 2001 May 29;40(21):6303-18. doi: 10.1021/bi002670n.
5
Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.合成的1,4 - 蒽二酮类似物通过一种涉及半胱天冬酶 - 2激活但不涉及Fas信号传导的机制,诱导HL - 60细胞中的细胞色素c释放、半胱天冬酶 - 9、 - 3和 - 8活性、聚(ADP - 核糖)聚合酶 - 1裂解以及核小体间DNA片段化。
Biochem Pharmacol. 2004 Feb 1;67(3):523-37. doi: 10.1016/j.bcp.2003.09.012.
6
Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells.趋化因子调节激活蛋白(RANTES)激活Janus激酶2(Jak2)和Janus激酶3(Jak3),以调控T细胞中多种信号通路的参与。
J Biol Chem. 2001 Apr 6;276(14):11427-31. doi: 10.1074/jbc.M010750200. Epub 2001 Jan 18.
7
Synthesis and characterization of biologically functional biotinylated RANTES.具有生物功能的生物素化趋化因子RANTES的合成与表征
J Immunol Methods. 2002 Aug 1;266(1-2):53-65. doi: 10.1016/s0022-1759(02)00096-0.
8
Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans.与类肝素糖胺聚糖相互作用后RANTES、MIP-1α和MIP-1β功能的检测。
J Biol Chem. 2000 Apr 21;275(16):11721-7. doi: 10.1074/jbc.275.16.11721.
9
Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling.活化时正常T细胞表达和分泌的调节趋化因子(RANTES)与糖胺聚糖的可溶性复合物可抑制HIV-1感染,但不会诱导Ca(2+)信号传导。
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14499-504. doi: 10.1073/pnas.96.25.14499.
10
Glycans are involved in RANTES binding to CCR5 positive as well as to CCR5 negative cells.
Biochim Biophys Acta. 2001 Feb 9;1510(1-2):354-66. doi: 10.1016/s0005-2736(00)00368-0.

引用本文的文献

1
Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease.在糖尿病肾病的MOSAIC随机试验中,塞洛西布抑制ASK1的血浆蛋白质组特征与疗效相关。
BMC Nephrol. 2025 May 15;26(1):244. doi: 10.1186/s12882-025-04166-4.
2
Analysis and validation of hub genes for atherosclerosis and AIDS and immune infiltration characteristics based on bioinformatics and machine learning.基于生物信息学和机器学习的动脉粥样硬化与艾滋病核心基因分析、验证及免疫浸润特征研究
Sci Rep. 2025 Apr 10;15(1):12316. doi: 10.1038/s41598-025-96907-6.
3
Blockade of CCR5 T Cell Accumulation in the Tumor Microenvironment Optimizes Anti-TGF-β/PD-L1 Bispecific Antibody.
阻断 CCR5 在肿瘤微环境中的 T 细胞聚集可优化抗 TGF-β/PD-L1 双特异性抗体。
Adv Sci (Weinh). 2024 Nov;11(43):e2408598. doi: 10.1002/advs.202408598. Epub 2024 Sep 20.
4
CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization.CCL18 通过诱导 CCR6 依赖性 T 细胞浸润和极化加剧动脉粥样硬化。
Front Immunol. 2024 May 13;15:1327051. doi: 10.3389/fimmu.2024.1327051. eCollection 2024.
5
Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.趋化因子谱的病原体特异性 T 细胞 I:效应 T 细胞。
J Immunol. 2020 Oct 15;205(8):2169-2187. doi: 10.4049/jimmunol.2000253. Epub 2020 Sep 18.
6
Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.靶向趋化因子-糖胺聚糖相互作用抑制炎症。
Front Immunol. 2020 Mar 31;11:483. doi: 10.3389/fimmu.2020.00483. eCollection 2020.
7
[CCR5 antagonists and HIV-1 infection: Bases and consequences of this therapeutic approach].[CCR5拮抗剂与HIV-1感染:这种治疗方法的基础与后果]
Antibiotiques (Paris). 2010 Mar;12(1):27-41. doi: 10.1016/j.antib.2010.01.006. Epub 2010 Feb 18.
8
Oncogenic Linear Collagen VI of Invasive Breast Cancer Is Induced by CCL5.侵袭性乳腺癌的致癌性线性胶原蛋白VI由CCL5诱导产生。
J Clin Med. 2020 Apr 2;9(4):991. doi: 10.3390/jcm9040991.
9
The role of ischemic preconditioning in the expression of apoptosis-related genes in a rat model of intestinal ischemia-reperfusion injury.缺血预处理在大鼠肠缺血再灌注损伤模型中凋亡相关基因表达中的作用。
Acta Cir Bras. 2019;34(5):e201900501. doi: 10.1590/s0102-865020190050000001. Epub 2019 Jun 3.
10
DSE regulates the malignant characters of hepatocellular carcinoma cells by modulating CCL5/CCR1 axis.二氢杨梅素通过调节CCL5/CCR1轴来调控肝癌细胞的恶性特征。
Am J Cancer Res. 2019 Feb 1;9(2):347-362. eCollection 2019.